On February 19, 2024, Gain Therapeutics, Inc. received notice of the resignation of C. Evan Ballantyne as the Company's Chief Financial Officer, and all other positions held at the Company, to be effective March 1, 2024. On February 21, 2024, the Board of Directors of the company appointed Gianluca Fuggetta, the Company's current Senior Director, Finance & Corporate Reporting and Principal Accounting Officer, as the Company's Vice President of Finance and to also serve as the Company's Principal Financial Officer, to be effective March 1, 2024. The Company has initiated a search to identify its next Chief Financial Officer.

Mr. Fuggetta, age 35, has served as the Company's Senior Director and Principal Accounting Officer since January 2023 and served as the Company's Finance Director from July 2022 to December 2022. Prior to joining the Company, Mr. Fuggetta held various positions of increasing responsibility at PricewaterhouseCoopers from September 2013 until June 2022, most recently holding the position of Assurance Manager. He earned a B.S. in Business Administration and Management at the Universit Cattolica del Sacro Cuore and a Master's in Accounting, Auditing and Control at the Universit Bocconi.